Login / Signup

Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy.

Vipawee S ChatDonovan G KearnsShelley K UppalJashin J Wu
Published in: The Journal of dermatological treatment (2019)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • mycobacterium tuberculosis
  • peritoneal dialysis
  • prognostic factors
  • stem cells
  • mesenchymal stem cells
  • bone marrow
  • cell therapy